1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. FDA Oncology Center of Excellence Presents: Conversations on Cancer: “Endometrial Cancer: Rising incidence. Rising innovation.” - 09/18/2025
  1. FDA Meetings, Conferences and Workshops

Webcast | Virtual

Event Title
FDA Oncology Center of Excellence Presents: Conversations on Cancer: “Endometrial Cancer: Rising incidence. Rising innovation.”
September 18, 2025

Date:
September 18, 2025
Time:
12:00 p.m. - 1:00 p.m. ET
Organized By:
Organizer
Image
FDA Oncology Center

X (formerly Twitter):  #ConversationsonCancer 

Sponsored by the U.S. Food & Drug Administration (FDA)

Background: 

In 2025, an estimated 69,120 new cases of endometrial cancer will be diagnosed in the United States, with approximately 13,860 deaths expected. Endometrial cancer has become both the most common and the deadliest gynecologic malignancy. Endometrial cancer is also the cancer with the greatest annual increase in death rates among women. Despite rising incidence and mortality rates, new drug development has progressed slowly and for decades, patients faced a devastating treatment desert. After the first drug, a hormonal therapy, was approved in 1971, patients waited 48 years for the next breakthrough. While we've seen promising immunotherapy advances since 2019, too many patients still face limited options when these treatments fail. 

Join us for an engaging discussion that will bring together key stakeholders, including representatives from the patient advocacy community, academia, and community oncology to discuss the historical path that has led us to the current treatment landscape, the trends in the numbers of new cases and deaths, areas of ongoing high impact research, and what the future might bring.

Webcast Information: 

A free-of-charge webcast of this program can be viewed on Thursday, September 18, 2025, beginning at 12:00 pm EST on YouTube at: https://youtube.com/live/pe1JoXMoaCY               
FDA plans to post a webcast of this Conversations on Cancer program at: https://www.youtube.com/user/USFoodandDrugAdmin/search

Contact:

For any inquiries regarding this program, please send an email to: OCE-Engagement@fda.hhs.gov

Back to Top